Physician profile
Justin West
NPI 1376791616
$30,990.03
in general payments reported to CMS, 2019-2025
17 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $784 · 2020: $259 · 2021: $292 · 2022: $655 · 2023: $420 · 2024: $9,149 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Food and Beverage: $1,219 · Long Term Medical Supply Or Device Loan: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,679.44 |
| Food and Beverage | $1,219.31 |
| Long Term Medical Supply Or Device Loan | $1,102.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb Sa | $17,332.44 | 2025 | |
| Abbvie INC. | $9,210.65 | 2023-2025 | |
| Integra Lifesciences Corporation | $1,390.37 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Mentor Worldwide LLC | $1,270.37 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Allergan, INC. | $632.80 | 2019-2022 | |
| Ucb, INC. | $320.00 | 2025 | |
| Sientra, INC. | $283.87 | 2019-2022 | |
| Baxter Healthcare | $171.43 | 2023 | Artiss |
| Rti Surgical, INC | $150.00 | 2025 | |
| Galderma Laboratories, L.P. | $88.88 | 2019-2020 | |
| Motiva USA, LLC | $32.81 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $25.67 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.99 | 2019 | |
| Merck Sharp & Dohme LLC | $19.61 | 2019 | |
| Mylan Institutional INC. | $19.15 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.58 | 2019 | |
| Apyx Medical Corporation | $2.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.